BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 27986722)

  • 1. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.
    Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB
    Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
    Tiwari V; Meena K; Tiwari M
    Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.
    Ragupathi NKD; Bakthavatchalam YD; Mathur P; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B
    Indian J Med Res; 2019 Feb; 149(2):222-231. PubMed ID: 31219087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
    Sivinski J; Ambrose AJ; Panfilenko I; Zerio CJ; Machulis JM; Mollasalehi N; Kaneko LK; Stevens M; Ray AM; Park Y; Wu C; Hoang QQ; Johnson SM; Chapman E
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the main MDR pathogens: prevalence and treatment options.
    Esposito S; De Simone G
    Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa by multiplex PCR.
    Thong KL; Lai MY; Teh C SJ; Chua KH
    Trop Biomed; 2011 Apr; 28(1):21-31. PubMed ID: 21602765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens.
    Michiels JE; Van den Bergh B; Verstraeten N; Fauvart M; Michiels J
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4630-7. PubMed ID: 27185802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence similarity searches for morphine biosynthesis enzymes in bacteria yield putative targets for understanding associations between infection and opiate administration.
    Zhan SH; French L
    J Med Microbiol; 2019 Jun; 68(6):952-956. PubMed ID: 31107204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid identification of ESKAPE bacterial strains using an autonomous microfluidic device.
    Ho JY; Cira NJ; Crooks JA; Baeza J; Weibel DB
    PLoS One; 2012; 7(7):e41245. PubMed ID: 22848451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatives for the treatment of infections caused by ESKAPE pathogens.
    da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
    J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rMAP: the Rapid Microbial Analysis Pipeline for ESKAPE bacterial group whole-genome sequence data.
    Sserwadda I; Mboowa G
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34110280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-powered integrated microfluidic point-of-care low-cost enabling (SIMPLE) chip.
    Yeh EC; Fu CC; Hu L; Thakur R; Feng J; Lee LP
    Sci Adv; 2017 Mar; 3(3):e1501645. PubMed ID: 28345028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of the ESKAPE pathogens.
    Pendleton JN; Gorman SP; Gilmore BF
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
    Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
    Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19.
    Durán-Manuel EM; Cruz-Cruz C; Ibáñez-Cervantes G; Bravata-Alcantará JC; Sosa-Hernández O; Delgado-Balbuena L; León-García G; Cortés-Ortíz IA; Cureño-Díaz MA; Castro-Escarpulli G; Vélez-Reséndiz JM; Bello-López JM
    J Infect Dev Ctries; 2021 Jan; 15(1):58-68. PubMed ID: 33571146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections.
    Qian Y; Zhou D; Li M; Zhao Y; Liu H; Yang L; Ying Z; Huang G
    Front Cell Infect Microbiol; 2023; 13():1223696. PubMed ID: 37662004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of recombinase polymerase amplification in the detection of
    Jin XJ; Gong YL; Yang L; Mo BH; Peng YZ; He P; Zhao JN; Li XL
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):233-239. PubMed ID: 29690742
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health.
    Denissen J; Reyneke B; Waso-Reyneke M; Havenga B; Barnard T; Khan S; Khan W
    Int J Hyg Environ Health; 2022 Jul; 244():114006. PubMed ID: 35841823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
    El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.